Prr23a2, a member of the proline-rich 23A gene family, exhibits specific expression in facial tissues, suggesting a pivotal role in facial development or maintenance. The target gene's precise function remains an intriguing aspect of cellular physiology, potentially contributing to facial tissue homeostasis or specialized functions. Understanding the activation mechanisms of Prr23a2 is essential for unraveling its significance in facial tissue biology. Activation of Prr23a2 involves intricate regulatory networks influenced by various chemicals. Retinoic Acid, a key player in gene expression regulation, directly up-regulates Prr23a2 by binding to its regulatory regions, promoting transcription in facial tissues. Chromatin-modifying agents like Trichostatin A and Butyrate indirectly enhance Prr23a2 by affecting chromatin structure, potentially influencing its expression in facial tissues.
Additionally, compounds like Sulforaphane and Valproic Acid modulate redox signaling and histone acetylation, respectively, indirectly impacting Prr23a2 expression. Forskolin and N-Acetyl Cysteine, through cAMP modulation and redox state influence, respectively, may indirectly contribute to Prr23a2 up-regulation in facial tissues. The vitamin A derivatives, Vitamin A and Retinol, serve as precursors for retinoic acid synthesis, potentially influencing Prr23a2 expression in facial tissues. L-Mimosine and SB431542 modulate HIF-1α and TGF-β signaling, respectively, providing indirect mechanisms for impacting Prr23a2 expression in facial tissues. In summary, Prr23a2, expressed specifically in facial tissues, holds promise as a key player in facial development or maintenance. Its activation involves a sophisticated interplay of chemicals influencing gene expression, chromatin structure, and signaling pathways. Deciphering the nuanced mechanisms governing Prr23a2's role in facial tissue biology opens avenues for exploring its functional significance in the intricate processes shaping facial development and homeostasis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
A key regulator of gene expression through activation of retinoic acid receptors. Directly up-regulates Prr23a2 by binding to its regulatory regions, enhancing transcription and promoting expression in facial tissues. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
HDAC inhibitor affecting chromatin structure. Indirectly activates Prr23a2 by promoting an open chromatin state, facilitating transcription factor accessibility and enhancing gene expression in facial tissues. | ||||||
Vitamin A | 68-26-8 | sc-280187 sc-280187A | 1 g 10 g | $385.00 $2654.00 | ||
Precursor of retinoic acid, impacting gene expression. Indirectly stimulates Prr23a2 by providing a source for retinoic acid synthesis, contributing to facial tissue-specific up-regulation. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Activator of Nrf2 signaling, influencing gene expression. Indirectly up-regulates Prr23a2 by enhancing the antioxidant response element (ARE)-mediated transcription, potentially influencing its expression in facial tissues. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
HDAC inhibitor affecting gene expression. Indirectly activates Prr23a2 by promoting an open chromatin state, influencing transcriptional activity and potentially enhancing expression in facial tissues. | ||||||
N-Acetyl-L-cysteine | 616-91-1 | sc-202232 sc-202232A sc-202232C sc-202232B | 5 g 25 g 1 kg 100 g | $34.00 $74.00 $270.00 $114.00 | 34 | |
Precursor of glutathione, modulating redox signaling. Indirectly influences Prr23a2 by impacting cellular redox state, potentially contributing to its expression in facial tissues. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
HDAC inhibitor affecting chromatin remodeling. Indirectly activates Prr23a2 by modulating histone acetylation, potentially influencing its expression in facial tissues. | ||||||
Limonin | 1180-71-8 | sc-204793 sc-204793A sc-204793B | 50 mg 100 mg 500 mg | $67.00 $84.00 $333.00 | ||
Inducer of hypoxia-inducible factor-1α (HIF-1α). Indirectly influences Prr23a2 by modulating HIF-1α-dependent gene expression, potentially impacting its expression in facial tissues. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
Inhibitor of TGF-β type I receptor. Modulates TGF-β signaling, potentially influencing Prr23a2 expression in facial tissues. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Modulator of NF-κB signaling. Indirectly influences Prr23a2 by affecting NF-κB-dependent gene expression, potentially impacting its expression in facial tissues. | ||||||